Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fospropofol Disodium vs Sevoflurane for Postoperative Delirium in Elderly Abdominal Tumor Surgery
ChiCTR2600119084Phase 4Recruiting
- Sponsor
- Chongqing University Cancer Hospital
- Start
- Feb 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fospropofol disodium in postoperative delirium (POD) (2 arms), sponsored by Chongqing University Cancer Hospital. Primary endpoint: postoperative delirium incidence. Started Feb 2026; status: recruiting.
02
Drugs
fospropofol disodium
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2600119084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119084.